Study at a glance
Why can rare vitamin D receptor disorders cause hair loss?
The vitamin D receptor helps hair follicles maintain their growth cycle. Some inherited defects remove the receptor or damage functions needed for that cycle, causing hair loss alongside the effects on calcium and bone.
Why do some affected people keep their hair?
Different gene changes damage different receptor functions. Some greatly weaken the response to active vitamin D while leaving the hair growth cycle intact. This supports a role for the receptor in hair follicles that does not depend on its usual signal from active vitamin D.
Does this mean vitamin D supplements will treat ordinary hair loss?
No. These findings concern rare inherited disorders and experimental models. They do not show that common hair loss usually comes from these gene changes or that taking more vitamin D will correct it.
Read the full article below ↓Alopecia in hereditary VDR disorders is scientifically useful because it does not simply track the severity of resistance to 1,25-dihydroxyvitamin D. Some mutations cause profound endocrine resistance without hair loss, while others that remove receptor expression, DNA binding or selected dimerisation functions are strongly associated with alopecia. That pattern reveals a VDR requirement in hair-follicle biology that cannot be explained by classical ligand-dependent mineral signalling alone.
For the wider rare-disease mutation spectrum and mineral phenotype, see Pathogenic VDR Mutations and Hereditary Vitamin D-Resistant Rickets.
Hair loss does not simply mean ‘more severe HVDRR’
HVDRR causes resistance to 1,25-dihydroxyvitamin D, impaired intestinal calcium absorption and the familiar mineral consequences of hypocalcaemia, secondary hyperparathyroidism, hypophosphataemia and rickets. Alopecia is different: it occurs in only a subset of affected children and depends strongly on the molecular class of the VDR defect. The hair phenotype therefore provides a second readout of receptor biology rather than a simple severity scale for the endocrine disease.
DNA-binding defects and absent receptor are particularly informative
Malloy and Feldman’s synthesis of human mutations reports a consistent pattern. Mutations that abolish VDR expression, disrupt the receptor’s DNA-binding function or impair RXR heterodimerisation are associated with alopecia. DNA-binding-domain mutations are especially striking because ligand binding can remain intact while DNA interaction fails. Severe hormone resistance plus alopecia in that setting points toward a requirement for an intact receptor: DNA regulatory apparatus in hair cycling.
The 2014 patient study gives the pattern concrete examples. A C60W mutation in the second zinc finger of the DNA-binding domain was completely inactive in transactivation assays and occurred with alopecia. Across the mutation catalogue summarised by the authors, DNA-binding-domain mutations were strongly associated with hair loss.
Ligand-binding and coactivator defects can separate endocrine resistance from hair cycling
The converse cases are equally important. Mutations that lower VDR affinity for 1,25-dihydroxyvitamin D or disrupt coactivator interactions can cause severe hormone resistance without alopecia. In the five-patient report, D144N and R158C ligand-binding-domain defects were examples in which rickets and hormone resistance occurred without hair loss. A compound-heterozygous patient carrying a DNA-binding-domain mutation together with an N276Y ligand-binding-domain allele also lacked alopecia, suggesting that the second allele could preserve a hair-relevant receptor function even though it did not prevent the mineral phenotype.
This is the critical natural experiment. If hair cycling depended simply on ligand-induced transcriptional potency, then mutations that severely weaken ligand binding should consistently produce alopecia. They do not. The mutation pattern instead supports a function of VDR in hair follicles that can persist when canonical ligand-dependent activation is badly impaired.
Why the evidence points to an unliganded VDR function
The human mutation pattern converges with model evidence discussed in the authorised reviews. People with vitamin D deficiency or defects in 1α-hydroxylase do not show the same characteristic alopecia, whereas loss of VDR itself does. In VDR-null mice, restoring wild-type VDR in keratinocytes can restore hair cycling. These comparisons separate absence of ligand production from absence of the receptor protein and support the conclusion that the receptor has a hair-follicle role that does not require the classical ligand signal in the same way as mineral metabolism.
Calling this ‘ligand-independent’ or ‘unliganded’ does not mean VDR has no ligand-dependent actions in skin. It means the hair-cycle requirement exposed by these genetic comparisons cannot be reduced to the receptor’s ordinary calcitriol-dependent endocrine action.
The receptor probably works with a hair-follicle regulatory programme
The exact downstream mechanism remains incompletely resolved. The alopecia phenotype of VDR loss resembles disorders involving the hairless (HR) corepressor pathway, and experimental work has implicated interactions among VDR, HR and broader pathways involved in keratinocyte and hair-follicle differentiation. Human mutation evidence therefore identifies the requirement for receptor integrity more strongly than it identifies one final molecular pathway.
What the evidence does not establish
The authorised evidence is derived from a rare Mendelian disorder, small patient series and mechanistic synthesis. It does not imply that ordinary hair loss in the general population is usually caused by VDR mutations or that increasing vitamin D exposure will correct alopecia. Nor does it make alopecia inevitable in HVDRR. The scientifically useful conclusion is narrower: mutation class separates the receptor’s ligand-dependent endocrine role from a receptor-dependent hair-follicle function.
Primary evidence used in this synthesis
- Mutations in the vitamin D receptor and hereditary vitamin D-resistant rickets · BoneKEy Rep. 2014;3:510. DOI: 10.1038/bonekey.2014.5.
- Vitamin D Receptor Mutations in Patients with Hereditary 1,25-Dihydroxyvitamin D-Resistant Rickets · Mol Genet Metab. 2014. DOI: 10.1016/j.ymgme.2013.10.014.
- The role of vitamin D receptor mutations in the development of alopecia · Mol Cell Endocrinol. 2011;347(1 to 2):90 to 96. DOI: 10.1016/j.mce.2011.05.045.
Related reading
Association Between Serum Trace Elements Level and Alopecia Areata: A Systematic Review and Meta‐Analysis
This research aimed to thoroughly and systematically assess the relationship between serum trace element levels and AA.
Original paper ↗Read more →Cardiometabolic Risk Factors in Rosuvastatin-Treated Men with Mixed Dyslipidemia and Early-Onset Androgenic Alopecia
The purpose of this research was to investigate levels of cardiometabolic risk factors in 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA)-treated men with early-onset androgenic alopecia.
Original paper ↗Read more →Clinical characteristics and factors associated with different BASP subtypes of androgenetic alopecia
This study aimed to explore the associated factors for different basic and specific (BASP) classification subtypes of androgenic alopecia (AGA).
Original paper ↗Read more →Differential sensitivity of epidermal cell subpopulations to β-catenin-induced ectopic hair follicle formation
Wnt signalling is required for hair follicle development and for the growth phase (anagen) of postnatal follicles.
Original paper ↗Read more →Factors associated with early-onset androgenetic alopecia: A scoping review
Among the 65 eligible articles, 67.69% were case-control studies and 78.46% evaluated only male patients.
Original paper ↗Read more →Fractional carbon dioxide laser alone and as an assisted drug delivery for treatment of alopecia areata: a clinical, dermoscopic and immunohistochemical study
This research aimed to evaluate the effectiveness of fractional carbon dioxide laser (FCL) alone or combined with triamcinolone acetonide (TA) solution, platelet-rich plasma (PRP), or vitamin D3 solution in treating AA.
Original paper ↗Read more →Impaired metabolic effects of metformin in men with early-onset androgenic alopecia
The purpose of the current study was to investigate whether the presence of early-onset male-pattern baldness modulates metabolic effects of metformin.
Original paper ↗Read more →Longitudinal biomarker trajectories accompanying trichoscopic change after PRP-based regimens for alopecia: a complementary multi-marker analysis of a real-world cohort
This study aimed to provide a complementary longitudinal analysis of the same real-world treatment cohort, focusing on within-subject trichoscopic change and paired biomarker trajectories rather than on baseline response stratification.
Original paper ↗Read more →Non-Cicatricial Alopecia and Its Association with Anthropometric Measurements and Nutritional Laboratory Markers
The aim of this study was to investigate the relationship between anthropometric and nutritional laboratory parameters in Caucasian adult women and men with non-cicatricial alopecia.
Original paper ↗Read more →The Role of Vitamin D in Non-Scarring Alopecia
Since any disturbances in the hair follicle cycle may lead to hair shedding, or alopecia, it is not surprising that the possible role of vitamin D in alopecia was investigated in many studies.
Original paper ↗Read more →The role of vitamin D receptor signaling in hair follicle health and alopecia: Current understanding and therapeutic implications
Vitamin D receptor (VDR) signaling plays a crucial role in hair follicle biology and represents a promising therapeutic target for various forms of alopecia.
Original paper ↗Read more →The Vitamin D Receptor Is a Wnt Effector that Controls Hair Follicle Differentiation and Specifies Tumor Type in Adult Epidermis
We have investigated how Wnt and vitamin D receptor signals regulate epidermal differentiation.
Original paper ↗Read more →Pathogenic VDR Mutations and Hereditary Vitamin D-Resistant Rickets: Evidence Synthesis
Evidence synthesis of pathogenic VDR mutations, hereditary vitamin D-resistant rickets and genotype-to-molecular-defect relationships.
Read more →Hereditary 1,25-dihydroxyvitamin D-resistant rickets (HVDRR) caused by a VDR mutation: A novel mechanism of dominant inheritance
In this report, we aimed to confirm whether HVDRR is occasionally inherited as a dominant trait.
Original paper ↗Read more →Functional Analysis of VDR Gene Mutation R343H in A Child with Vitamin D-Resistant Rickets with Alopecia
The functional study of different mutations on vitamin D receptor (VDR) gene causing hereditary vitamin D-resistant rickets (HVDRR) remains limited.
Original paper ↗Read more →Gene therapy for alopecia in type II rickets model rats using vitamin D receptor-expressing adenovirus vector
On the other hand, control-AdV was injected into 7-week-old female rats (control-AdV rats); non-infected Vdr-KO rats (control rats) were also examined.
Original paper ↗Read more →Role of vitamin D and calcium signaling in epidermal wound healing
This review will discuss the role of vitamin D and calcium signaling in the epidermal wound response with particular focus on the stem cells of the epidermis and hair follicle that contribute to the wounding response.
Original paper ↗Read more →Vitamin D-Resistant Rickets and Cinacalcet: One More Favorable Experience
Hereditary vitamin D-resistant rickets (HVDRR) is an autosomal recessive disorder characterized by early onset of severe rickets, with a complete triad of clinical, biochemical and skeletal abnormalities.
Original paper ↗Read more →Characterization of Rickets Type II Model Rats to Reveal Functions of Vitamin D and Vitamin D Receptor
GM rats exhibited markedly elevated plasma parathyroid hormone and 1,25D3 levels compared to those of WT rats.
Original paper ↗Read more →Coactivator-independent vitamin D receptor signaling causes severe rickets in mice, that is not prevented by a diet high in calcium, phosphate, and lactose
The vitamin D receptor (VDR) plays a critical role in the regulation of mineral and bone homeostasis.
Original paper ↗Read more →Vitamin D Levels, Biomarker Status and Biological Effect: Evidence Synthesis
An evidence synthesis explaining what vitamin D levels measure and why circulating 25(OH)D status can differ from downstream biological effect.
Read more →Original sources
Mutations in the vitamin D receptor and hereditary vitamin D-resistant rickets
Published in · BoneKEy Rep (2014).
Publication details
Mutations in the vitamin D receptor and hereditary vitamin D-resistant rickets · BoneKEy Rep. 2014;3:510. DOI: 10.1038/bonekey.2014.5.
Vitamin D Receptor Mutations in Patients with Hereditary 1,25-Dihydroxyvitamin D-Resistant Rickets
Published in · Mol Genet Metab (2014).
Publication details
Vitamin D Receptor Mutations in Patients with Hereditary 1,25-Dihydroxyvitamin D-Resistant Rickets · Mol Genet Metab. 2014. DOI: 10.1016/j.ymgme.2013.10.014.
The role of vitamin D receptor mutations in the development of alopecia
Published in · Mol Cell Endocrinol (2011).
Publication details
The role of vitamin D receptor mutations in the development of alopecia · Mol Cell Endocrinol. 2011;347(1 to 2):90 to 96. DOI: 10.1016/j.mce.2011.05.045.